Sign in

CIK 0001534969 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
261911522
Phone
(801) 990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-10 Jackson Benjamin General Counsel Sale −2,190 $2.00 $4K 159,566
2026-06-11 Jackson Benjamin General Counsel Sale −2,179 $2.01 $4K 161,756
2026-05-29 Jackson Benjamin General Counsel Grant or award +5,000 $1.84 $9K 163,935
2026-03-12 Jackson Benjamin General Counsel Grant or award +44,215 158,935
2026-03-12 Jackson Benjamin General Counsel Grant or award · Stock Option (right to buy) +68,550 68,550
2026-03-11 Jackson Benjamin General Counsel Sale −1,027 $2.04 $2K 114,720
2026-03-09 Jackson Benjamin General Counsel Sale −3,119 $1.96 $6K 115,747
2025-12-10 Jackson Benjamin General Counsel Sale −892 $3.31 $3K 118,866
2025-11-10 Jackson Benjamin General Counsel Sale −7,059 $2.62 $18K 119,758
2025-09-11 Jackson Benjamin General Counsel Sale −934 $3.13 $3K 126,817
2025-08-08 Jackson Benjamin General Counsel Sale −6,447 $2.54 $16K 127,751
2025-06-10 Jackson Benjamin General Counsel Sale −965 $1.48 $1K 134,198

Page 1 of 1 · 12 trades